How does adopting DBT impact an imaging provider’s screening volumes?

Adopting digital breast tomosynthesis (DBT) at your facility does not lead to a drop in monthly breast cancer screening volumes, according to new research published in the American Journal of Roentgenology.

“The present study … shows no evidence of decreased capacity for breast cancer imaging after DBT adoption,” wrote lead author Christoph I. Lee, MD, MS, MBA, with the department of radiology at the University of Washington School of Medicine in Seattle, and colleagues. 

Click here to read the full article in Radiology Business.

Share this story: